Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase 1/2 Trial of ADI-212 in mCRPC

This is a Phase 1/2 multicenter, open-label, dose finding and dose expansion study of ADI-212 in participants with metastatic castration-resistant prostate cancer (mCRPC)

Participants needed: 12
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: MaleType: InterventionalSponsor: Adicet TherapeuticsUpdated: Sep 10, 2026Locations: 1
Eligibility criteria

Histologic and/or cytologic confirmation of adenocarcinoma of the prostate [+14]

Prior radiation therapy within 21 days prior to start of study treatment [+12]

Status: Recruiting

A Phase 1 Study of ADI-001 in Rheumatoid Arthritis

ADI-001-106 is a phase 1 study of ADI-001 with a randomized, single-blind, parallel group design to compare two different LD regimens in subjects with treatment-refractory RA. The study will consist of different periods including screening, LD, treatment, and follow-up

Participants needed: 25
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Adicet TherapeuticsUpdated: Dec 8, 2025Locations: 1
Eligibility criteria

≥ 18 years of age. [+3]

Presence of severe liver disease, Child-Pugh class B or C. [+3]